WallStreetZenWallStreetZen

NASDAQ: UNCY
Unicycive Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Unicycive Therapeutics earnings were -$26.6M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest UNCY earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$14.7M, up 144% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, UNCY reported annual earnings of -$26.6M, with -29.8% growth.

UNCY earnings history

Current Revenue
$0.0
Current Earnings
-$26.6M
Current Profit Margin
0%

UNCY Return on Equity

Current Company
-111.4%
Current Industry
-31.4%
Current Market
28.9%
UNCY's Return on Equity (-111.4%)... subscribe to Premium to read more.
High Return on Equity Performance

UNCY Return on Assets

Current Company
-67.4%
Current Industry
-9.6%
UNCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when UNCY announces earnings.

UNCY Return on Capital Employed

Current Company
-87.7%
Current Industry
-3.7%
UNCY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UNCY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
UNCY-$25.91M-$26.56MN/A-$1.67
SGMT-$50.89M-$51.04MN/A-$1.58
NKTX-$92.94M-$104.08MN/A-$1.41
GALT-$23.45M-$30.97MN/A-$0.48
RNAC-$135.76M-$130.30MN/A-$5.02
View Top Biotech Stocks

Unicycive Therapeutics Earnings Reports & History FAQ

What were Unicycive Therapeutics's earnings last quarter?

Unicycive Therapeutics (NASDAQ: UNCY) reported Q4 2025 earnings per share (EPS) of -$0.82, up 68.94% year over year. Total UNCY earnings for the quarter were -$14.67 million. In the same quarter last year, Unicycive Therapeutics's earnings per share (EPS) was -$2.64.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.

Is Unicycive Therapeutics profitable or losing money?

As of the last Unicycive Therapeutics earnings report, Unicycive Therapeutics is currently losing money. Unicycive Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$26.56 million, a 27.7% decrease year over year.

What was UNCY's earnings growth in the past year?

As of Unicycive Therapeutics's earnings date in Q2 2026, Unicycive Therapeutics's earnings has grown year over year. UNCY earnings in the past year totalled -$26.56 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.